Barbier, François
Hraiech, Sami
Kernéis, Solen
Veluppillai, Nathanaël
Pajot, Olivier
Poissy, Julien
Roux, Damien
Zahar, Jean-Ralph
,
Article History
Received: 20 April 2023
Accepted: 9 June 2023
First Online: 18 July 2023
Declarations
:
: Not applicable.
: Not applicable.
: FB declares having received lecture and consulting fees from MSD, lecture fees for BioMérieux and conference invitation from Pfizer. SH declares having received a conference invitation from Shionogi and lecture fees from Pfizer. OP declares having received consulting fees and conference invitation from MSD, and conference invitation from Correvio. JP declares having received lecture fees from Gilead. JRZ declares having received lecture fees from MSD, Pfizer, Shinogi and BioMérieux, and conference invitations from MSD and Pfizer. All other authors declare having no potential conflict of interest related to this article.